Cancer - Tscan Therapeutics
Cancer
Status:
Active, open to accrualClinicalTrials.gov:
NCT05812027Screening Study to Determine HLA Type, HLA Loss of Heterozygosity Status and Tumor Antigen Expression in Participants with Locally Advanced (Unresectable) or Metastatic Solid Tumors